盐酸乐卡地平片在中国健康受试者中单次空腹口服给药的一项随机、开放、三周期、三序列部分重复交叉生物等效性试验
[Translation] A randomized, open-label, three-period, three-sequence partially repeated crossover bioequivalence study of lercanidipine hydrochloride tablets after a single oral administration on an empty stomach in healthy Chinese subjects
观察健康受试者空腹单次口服由沈阳天邦药业有限公司生产的受试制剂盐酸乐卡地平片(规格:10 mg)后血药浓度经时过程,估算其药代动力学参数,并以原研进口 Recordati S.P.A.生产的盐酸乐卡地平片(商品名:再宁平®,规格:10 mg)为参比制剂,进行人体相
对生物利用度和生物等效性评价,为临床用药提供参考依据。
[Translation] The time course of blood drug concentration after a single oral administration of the test preparation Lercanidipine Hydrochloride Tablets (Specification: 10 mg) produced by Shenyang Tianbang Pharmaceutical Co., Ltd. on an empty stomach was observed in healthy subjects, and its pharmacokinetic parameters were estimated. The Lercanidipine Hydrochloride Tablets (trade name: Zainingping®, specification: 10 mg) produced by the original imported Recordati S.P.A. was used as the reference preparation to evaluate the relative bioavailability and bioequivalence in humans, providing a reference for clinical medication.
100 Clinical Results associated with Shenyang Tianbang Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Shenyang Tianbang Pharmaceutical Co., Ltd.
100 Deals associated with Shenyang Tianbang Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Shenyang Tianbang Pharmaceutical Co., Ltd.